Skip to main content
. 2022 Mar 1;12:834072. doi: 10.3389/fonc.2022.834072

Figure 2.

Figure 2

Major dysregulated pathways in cancer chemoresistance. Atg, autophagy-related; CAT, catalase; COX-2, cyclooxygenase; ERK, extracellular-regulated kinase; GSH, glutathione; HO-1, heme oxygenase 1; ILs, interleukins; iNOS, inducible nitric oxide synthase; JNK, c-Jun N-terminal kinase; LC3, microtubule-associated protein 1A/1B-light chain 3; MAPK, mitogen-activated protein kinase; MMP, matrix-metalloproteinase; mTOR, mammalian target of rapamycin; NLRP, nod-like receptor pyrin domain-containing; Nrf-2, nuclear factor-erythroid factor 2-related factor 2; PI3K, phosphoinositide 3-kinases; ROS, reactive oxygen species; SOD, superoxide dismutase; TNF-α, tumor necrosis factor-α.